ListarArtículos por tema "NAFLD"

Mostrando ítems 1-4 de 4

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease

Arab, J.P.; Dirchwolf, M.; Álvares-da-Silva, M.R.; Barrera, F.; Benítez, C.; Castellanos-Fernandez, M.; Castro-Narro, G.; Chavez-Tapia, N.; Chiodi, D.; Cotrim, H.; Cusi, K.; de Oliveira, C.P.M.S.; Díaz, J.; Fassio, E.; Gerona, S.; Girala, M.; Hernandez, N.; Marciano, S.; Masson, W.; Méndez-Sánchez, N.; Leite, N.; Lozano, A.; Padilla, M.; Panduro, A.; Paraná, R.; Parise, E.; Perez, M.; Poniachik, J.; Restrepo, J.C.; Ruf, A.; Silva, M.; Tagle, M.; Tapias, M.; Torres, Kenia; Vilar-Gomez, E.; Costa Gil, J.E.; Gadano, A.; Arrese, M. (Elsevier, 2020)

Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the general population. Furthermore, its prevalence ...
Non-alcoholic Fatty Liver Disease prevalence in Latin America: A systematic review and meta-analysis.

Rojas, Yesmi A. Ortega; Cuellar, Claudia L. Vidal; Barrón, Karina M. Aparicio; Verdugo, Juan Pablo Arab; Miranda, Adelina Lozano (Elsevier, 2022)

Non-alcoholic fatty liver disease (NAFLD) produces high morbidity and mortality rates. Its worldwide prevalence is 25%, but evidence from Latin America (LA) is lacking. We aimed to estimate the prevalence of NAFLD in the ...
Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III

Carrillo Larco, Rodrigo Martín; Guzman Vilca, Wilmer Cristobal; Castillo-Cara, M.; Alvizuri-Gómez, Claudia; Alqahtani, S.; Garcia-Larsen, V. (BMJ Group, 2022)

OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is a non-communicable disease with a rising prevalence worldwide and with large burden for patients and health systems. To date, the presence of unique phenotypes in ...
Sensitivity and specificity of three diabetes diagnostic criteria in people with non-alcoholic fatty liver disease (NAFLD) and otherwise healthy people: Analysis of NHANES III.

Carrillo-Larco, Rodrigo M.; Guzman Vilca, Wilmer Cristobal; Alvizuri-Gómez, Claudia; Tamim, Hani; Alqahtani, Saleh A.; García-Larsen, Vanessa (Elsevier, 2023)

AIMS: Establishing whether fasting plasma glucose (FPG), postprandial glucose (PPG), and HbA1c have the same diagnostic accuracy in NAFLD versus otherwise healthy people could inform T2DM screening recommendations for ...

ListarArtículos por tema "NAFLD"

ListarArtículos por tema "NAFLD"

Buscar en el Repositorio

Listar

Todo el Repositorio

Esta comunidad

Panel de Control